Impact of ultraviolet filters and polycyclic aromatic hydrocarbon from recreational activities on water reservoirs in southeast Queensland Australia.
Summary
Across 14 lakes over 3 years, 15 PAHs and six UV filters were detected; chrysene (97%) and octyl salicylate (34%) were most prevalent. PAHs were significantly higher in petrol-powered boating lakes in summer, while UV filters were higher where swimming was allowed, with evidence of illegal swimming at non-permitted sites. Although concentrations were below freshwater guidelines, bioaccumulation and mixture toxicity warrant mitigation.
Key Findings
- Detected 15 PAHs and six UV filters across 14 lakes; chrysene (97%) and octyl salicylate (34%) were most prevalent.
- PAH levels were significantly higher in petrol-powered boating lakes, especially in summer (p=0.005–0.05).
- UV filters were higher in lakes allowing swimming; elevated levels at non-permitted lakes suggested illegal swimming.
- All individual compounds were below freshwater guidelines, but bioaccumulation and mixture toxicity raise concern.
Clinical Implications
Dermatology and public health guidance can emphasize low-persistence UV filters and promote behaviors and policies (e.g., designated swimming areas, boating controls) that reduce environmental load without compromising photoprotection.
Why It Matters
This study links specific recreational behaviors to seasonal contamination patterns of PAHs and sunscreen UV filters in drinking water reservoirs, informing environmental health policy around cosmetic product use and recreation management.
Limitations
- Observational design limits causal inference; multiple confounders (lake size, hydrology) may influence levels
- No direct assessment of organismal toxicity or bioaccumulation in biota
Future Directions
Quantify bioaccumulation and mixture toxicity in aquatic organisms, model source contributions, and evaluate policy impacts of low-persistence UV filters and recreation management.
Study Information
- Study Type
- Cohort
- Research Domain
- Prevention
- Evidence Level
- III - Prospective longitudinal observational monitoring across multiple sites
- Study Design
- OTHER